Abstract Body

Despite our growing antiviral armamentarium and our clear appreciation on how HIV infection may be blocked, HIV continues to spread like wildfire in some communities globally. Thus a vaccine is desperately needed. The HIV vaccine community has experienced renewed optimism over the past decade due to: 1) our growing appreciation for novel unexpected immune correlates of infection in the RV144 vaccine trial that showed moderate protection from infection, as well as 2) our growing capacity to identify and mechanistically profile novel neutralizing antibodies with remarkable antiviral potency. However, despite these advances, to date, it is still incompletely understood how such responses can be induced via vaccination, or how they emerge naturally during infection.

Conclusion: This presentation will therefore highlight our current understanding of the immunological profile of “protective” anti-HIV immunity, will review the “rational” vaccine design strategies that are being exploited in the vaccine field, as well as dissect the unexplored and untapped research opporutinities in the field. Throughout the presentation, information will be provided on where and when the latest information will be presented at CROI.